PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Twelve Years of Handshake Stewardship: Use Fell 33%, Then Refinement

handshake stewardshipantimicrobial stewardshipprospective audit and feedbackdays of therapypediatricsanti-infectiveslinezolidvancomycinclindamycincarbapenemsintravenous to enteral conversionretrospective pre-post studyclinical pharmacy practice Clinical Practice

Background Information

Handshake stewardship reduces anti-infective use by 33% over 12 years.

Understanding handshake stewardship can guide pharmacists in optimizing anti-infective use, improving patient outcomes. A 33% reduction in anti-infective use was observed over 12 years, transitioning to a focus on optimal use. While specific to a pediatric hospital, the study supports the effectiveness and sustainability of handshake stewardship programs. Handshake stewardship effectively reduces anti-infective use, enhancing long-term antibiotic optimization.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Frappa KE, Weber MJ, Pearce K, Parker SK

Citation: Frappa KE, Weber MJ, Pearce K, et al. Handshake stewardship over a decade: refinement after successful implementation. Antimicrobial stewardship & healthcare epidemiology : ASHE. 2026;6(1):e297. doi:10.1017/ash.2026.10863

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.